Evaluating the benefits of increasing measles immunization rates

Health Services Research

Volumn 36, Issue 5, 2001, Pages 885-909

  Zwanziger, J ^a   Szilagyi, P G ^a   Kaul, P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cost benefit; Cost effectiveness; Immunization programs; Measles

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILD; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HUMAN; INCIDENCE; MEASLES; MEASLES VACCINATION; PREVENTIVE HEALTH SERVICE;

COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; HEALTH SERVICES RESEARCH; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MEASLES; MEASLES VACCINE; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; VALUE OF LIFE;

EID: 0034756303     PISSN: 00179124     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. The resurgence of measles in the United States, 1989-1990
2. Measles - United States, 1986
3. Measles - United States, 1987
4. Measles - United States, 1988
5. Measles - United States, 1989 and First 20 Weeks 1990
6. Measles - United States, 1990
7. Vaccine efforts in response to resurgence of Measles - U. S. 1989-1991
8. Public health surveillance: Where are we? Where are we going?
9. Retrospective assessment of immunization coverage among school-aged children - Selected U. S. Cities, 1991
10. Measles - United States, 1992
11. Reportable vaccine-preventable diseases - United States, 1993, and the childhood immunization initiative
12. Measles - United States, 1994
13. Measles - United States, 1995
14. Recommendations of the Advisory Committee on Immunization Practices: Programmatic strategies to increase vaccination coverage by age 2 years - Linkage to vaccination and WIC services
15. Measles - United States, 1996, and the interruption of indigenous transmission
16. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 1997
17. Achievements in public health, 1900-1999: Control of infectious diseases
18. Measles elimination in the Americas. Evolving strategies
19. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates
20. Markers for primary care: Missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city medicaid-eligible children
21. Herd immunity: History, theory, practice
22. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
23. Dollars may not buy as many QALYs as we think: A problem with defining quality-of-life adjustments
24. Predicting the quality of well-being scores from the SF-36: Results from the Beaver Dam Health Outcomes Study
25. Cost-benefit analysis of two strategies for prevention of haemophilus influenzae type B infection
26. Cost-benefit analysis of haemophilus influenzae type B prevention: Conjugate vaccination at eighteen months of age
27. Survival rates and causes of death among persons with nonspecific mental retardation
28. Pertussis and pertussis vaccine: Reanalysis of benefits, risks and costs
29. The case for global measles eradication
30. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the medical outcomes study 36-item short form health survey, EuroQoL, and disease specific measures
31. Simultaneous administration of childhood vaccines: An important public health policy that is sage and efficacious
32. A benefit-cost analysis of mumps vaccine
33. Pertussis vaccine: An analysis of benefits, risks and costs
34. Association of live births and the resurgence of measles
35. Towards eradication of measles virus: Global progress and strategy evaluation
36. Toward immunizing every child on time
37. A randomized study of tracking with outreach and provider prompting to improve immunization coverage and primary care
38. Is underimmunization a marker for insufficient utilization of preventive and primary care?
39. The role of cost-effectiveness analysis in health and medicine
40. Vaccines for children program, United States, 1997
41. Measles herd immunity - The association of attack rates with immunization rates in pre-school children
42. Recommendations for reporting cost-effectiveness analyses
43. Mathematical modeling and attempts to eliminate measles: A tribute to the late Professor George Macdonald
44. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the medical outcomes study
45. Benefits, risks and costs of immunization for measles, mumps and rubella
46. Immunization coverage among pre-school children: The United States and selected European countries